These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 20481572
41. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. Nishimori I, Minakuchi T, Morimoto K, Sano S, Onishi S, Takeuchi H, Vullo D, Scozzafava A, Supuran CT. J Med Chem; 2006 Mar 23; 49(6):2117-26. PubMed ID: 16539401 [Abstract] [Full Text] [Related]
42. Proton transfer pathways in the mutant His-64-Ala of human carbonic anhydrase II. Roy A, Taraphder S. Biopolymers; 2006 Aug 15; 82(6):623-30. PubMed ID: 16557501 [Abstract] [Full Text] [Related]
43. Ranking Power of the SQM/COSMO Scoring Function on Carbonic Anhydrase II-Inhibitor Complexes. Pecina A, Brynda J, Vrzal L, Gnanasekaran R, Hořejší M, Eyrilmez SM, Řezáč J, Lepšík M, Řezáčová P, Hobza P, Majer P, Veverka V, Fanfrlík J. Chemphyschem; 2018 Apr 05; 19(7):873-879. PubMed ID: 29316128 [Abstract] [Full Text] [Related]
44. Carbonic anhydrase II as host protein for the creation of a biocompatible artificial metathesase. Zhao J, Kajetanowicz A, Ward TR. Org Biomol Chem; 2015 May 28; 13(20):5652-5. PubMed ID: 25894419 [Abstract] [Full Text] [Related]
45. A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method. Oltulu O, Yaşar MM, Eroğlu E. Eur J Med Chem; 2009 Sep 28; 44(9):3439-44. PubMed ID: 19303173 [Abstract] [Full Text] [Related]
46. Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technology. Papalia GA, Leavitt S, Bynum MA, Katsamba PS, Wilton R, Qiu H, Steukers M, Wang S, Bindu L, Phogat S, Giannetti AM, Ryan TE, Pudlak VA, Matusiewicz K, Michelson KM, Nowakowski A, Pham-Baginski A, Brooks J, Tieman BC, Bruce BD, Vaughn M, Baksh M, Cho YH, Wit MD, Smets A, Vandersmissen J, Michiels L, Myszka DG. Anal Biochem; 2006 Dec 01; 359(1):94-105. PubMed ID: 17007806 [Abstract] [Full Text] [Related]
49. A new synthesis of difluoromethanesulfonamides--a novel pharmacophore for carbonic anhydrase inhibition. Boyle NA, Chegwidden WR, Blackburn GM. Org Biomol Chem; 2005 Jan 21; 3(2):222-4. PubMed ID: 15632962 [Abstract] [Full Text] [Related]
50. Coupled atomic charge selectivity for optimal ligand-charge distributions at protein binding sites. Bhat S, Sulea T, Purisima EO. J Comput Chem; 2006 Dec 21; 27(16):1899-907. PubMed ID: 16988958 [Abstract] [Full Text] [Related]
51. pKa analysis for the zinc-bound water in human carbonic anhydrase II: Benchmark for "multiscale" QM/MM simulations and mechanistic implications. Riccardi D, Cui Q. J Phys Chem A; 2007 Jul 05; 111(26):5703-11. PubMed ID: 17506534 [Abstract] [Full Text] [Related]
52. Molecular basis for the origin of differential spectral and binding profiles of dansylamide with human carbonic anhydrase I and II. Banerjee AL, Tobwala S, Ganguly B, Mallik S, Srivastava DK. Biochemistry; 2005 Mar 15; 44(10):3673-82. PubMed ID: 15751944 [Abstract] [Full Text] [Related]
53. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A, Klebe G. J Med Chem; 2004 Jan 29; 47(3):550-7. PubMed ID: 14736236 [Abstract] [Full Text] [Related]
54. Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors. Poli G, Jha V, Martinelli A, Supuran CT, Tuccinardi T. Int J Mol Sci; 2018 Jun 23; 19(7):. PubMed ID: 29937490 [Abstract] [Full Text] [Related]
55. Spectrally Resolved Estimation of Water Entropy in the Active Site of Human Carbonic Anhydrase II. Päslack C, Das CK, Schlitter J, Schäfer LV. J Chem Theory Comput; 2021 Aug 10; 17(8):5409-5418. PubMed ID: 34259506 [Abstract] [Full Text] [Related]
56. Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulphamate. Recacha R, Costanzo MJ, Maryanoff BE, Chattopadhyay D. Biochem J; 2002 Feb 01; 361(Pt 3):437-41. PubMed ID: 11802772 [Abstract] [Full Text] [Related]
57. New aromatic/heteroaromatic propanesulfonylhydrazone compounds: synthesis, physical properties and inhibition studies against carbonic anhydrase II (CAII) enzyme. Özmen Özdemir Ü, Altuntaş A, Gündüzalp AB, Arslan F, Hamurcu F. Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jul 15; 128():452-60. PubMed ID: 24682061 [Abstract] [Full Text] [Related]
58. Neutron structure of human carbonic anhydrase II: a hydrogen-bonded water network "switch" is observed between pH 7.8 and 10.0. Fisher Z, Kovalevsky AY, Mustyakimov M, Silverman DN, McKenna R, Langan P. Biochemistry; 2011 Nov 08; 50(44):9421-3. PubMed ID: 21988105 [Abstract] [Full Text] [Related]
59. The Influence of Varying Fluorination Patterns on the Thermodynamics and Kinetics of Benzenesulfonamide Binding to Human Carbonic Anhydrase II. Glöckner S, Ngo K, Wagner B, Heine A, Klebe G. Biomolecules; 2020 Mar 27; 10(4):. PubMed ID: 32230853 [Abstract] [Full Text] [Related]
60. Fluoroalkyl and alkyl chains have similar hydrophobicities in binding to the "hydrophobic wall" of carbonic anhydrase. Mecinović J, Snyder PW, Mirica KA, Bai S, Mack ET, Kwant RL, Moustakas DT, Héroux A, Whitesides GM. J Am Chem Soc; 2011 Sep 07; 133(35):14017-26. PubMed ID: 21790183 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]